RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

4,236

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 27, 2022

Study Completion Date

July 27, 2022

Conditions
Gastrointestinal ComplicationsProstate CancerSexual DysfunctionUrinary Complications
Interventions
DRUG

bicalutamide

DRUG

goserelin acetate

DRUG

leuprolide acetate

PROCEDURE

adjuvant therapy

PROCEDURE

quality-of-life assessment

RADIATION

radiation therapy

Trial Locations (58)

V1Y 5L3

British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna

V5Z 4E6

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver

N6A 4L6

London Regional Cancer Program at London Health Sciences Centre, London

K1Y 4E9

Ottawa Health Research Institute, Ottawa

M5G 2M9

Princess Margaret Hospital, Toronto

TN24 0LZ

William Harvey Hospital, Ashford

EX31 4JB

North Devon District Hospital, Barnstaple

RG24 9NA

Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke

B15 2TH

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham

BH7 7DW

Royal Bournemouth Hospital, Bournemouth

BD9 6RJ

Bradford Royal Infirmary, Bradford

BS10 5NB

Southmead Hospital, Bristol

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

CB2 2QQ

Addenbrooke's Hospital, Cambridge

CT1 3NG

Kent and Canterbury Hospital, Canterbury

CV2 2DX

Walsgrave Hospital, Coventry

CW1 4QJ

Mid Cheshire Hospitals Trust- Leighton Hopsital, Crewe

Unknown

Mayday University Hospital, Croydon

DN2 5LT

Doncaster Royal Infirmary, Doncaster

DT1 2JY

Dorset County Hospital, Dorchester

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

GU2 7XX

St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford

CM20 1QX

Princess Alexandra Hospital, Harlow

IP4 5PD

Ipswich Hospital, Ipswich

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

LN2 5QY

Lincoln County Hospital, Lincoln

N18 1QX

Helen Rollason Cancer Care Centre at North Middlesex Hospital, London

NW1 2BU

University College Hospital, London

SE1 9RT

Guy's Hospital, London

SW3 6JJ

Royal Marsden - London, London

ME16 9QQ

Maidstone Hospital, Maidstone

CH63 4JY

Clatterbridge Centre for Oncology, Manchester

M20 4BX

Christie Hospital, Manchester

TS4 3BW

James Cook University Hospital, Middlesbrough

HA6 2RN

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

PL6 8DH

Derriford Hospital, Plymouth

BH15 2JB

Dorset Cancer Centre, Poole Dorset

RM7 0AG

Queen's Hospital, Romford

S60 2UD

Rotherham General Hospital, Rotherham

M6 8HD

Hope Hospital, Salford

S1O 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

SO16 6YD

Southampton General Hospital, Southampton

SK2 7JE

Stepping Hill Hospital, Stockport

ST4 7LN

University Hospital of North Staffordshire, Stoke-on-Trent

SM2 5PT

Royal Marsden - Surrey, Sutton

TQ2 7AA

Torbay Hospital, Torquay

UB8 3NN

Hillingdon Hospital, Uxbridge

SS0 0RY

Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea

Y031 8HE

Cancer Care Centre at York Hospital, York

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

KA6 6DX

Ayr Hospital, Ayr

EH4 2XU

Edinburgh Cancer Centre at Western General Hospital, Edinburgh

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

WF1 4DG

Pinderfields General Hospital, Wakefield

LL 18 5UJ

Glan Clwyd Hospital, Bodelwyddan

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff

CF14 4XW

University Hospital of Wales, Cardiff

NP9 2UB

Royal Gwent Hospital, Newport

All Listed Sponsors
collaborator

Canadian Cancer Trials Group

NETWORK

lead

University College, London

OTHER

NCT00541047 - RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery | Biotech Hunter | Biotech Hunter